IPO investment, another revenue opportunity; Giant pharma company making condoms to bring IPO, application filed with SEBI – mankind pharma to launch could be one of largest ever in pharma sector files papers with sebi
Another big IPO
Apart from ChrysCapital, Capital International and Singapore’s GIC also have investments in Mankind Pharma. An IPO of a company can mainly come under an Offer for Sale (OFS). If the company comes up with this IPO, it could be the second largest IPO in the pharma sector. Gland Pharma holds the record for the largest IPO in this sector. Gland Pharma had an IPO of $869 million in November 2020.
Patanjali Mantra for Investment; 4 IPOs will be brought to the market..Baba Ramdev’s plan of 1 lakh crores!
Sale of 4 crore shares
4 crore (40,058,844) shares will be sold under Offer for Sale (OFS) by the promoters and existing shareholders of the company in the IPO. The promoters of the company are Ramesh Juneja, Rajeev Juneja, Sheetal Arora, Ramesh Juneja Family Trust, Rajeev Juneja Family Trust and Prem Sheetal Family Trust.
Earning opportunity during market volatility, ‘These’ stocks will be on investors’ radar…
Business of the company
Mankind Pharma was established in 1991. It is one of the leading pharmaceutical companies in India. Apart from branded generic drugs, the company’s leading brands include Prega-News pregnancy testing kit, Manforce condoms, Gas-O-Fast Ayurvedic antacid and acne treatment Acnestar. The company has 23 manufacturing facilities across India including the states of Himachal Pradesh, Sikkim, Rajasthan, Andhra Pradesh and Uttarakhand as on March 31, 2022. After India, US, Bangladesh, Sri Lanka and Nepal are the major markets.
